Tumescent Local Anesthesia Versus General Anesthesia for Subcutaneous Implantable Cardioverter-Defibrillator Implantation.

[1]  A. Natale,et al.  Tumescent Local Anesthesia Versus General Anesthesia for Subcutaneous Implantable Cardioverter Defibrillator Implantation: A Cost-Effectiveness Analysis. , 2022, Heart rhythm.

[2]  Yohei Kawatani,et al.  Application of ultrasound‐guided tumescent local anesthesia in prepectoral pacemaker implantation: A detailed procedural report , 2022, Journal of arrhythmia.

[3]  A. Natale,et al.  Tumescent local anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: An alternative for general anesthesia , 2021, HeartRhythm case reports.

[4]  Jayashree Venkataram,et al.  Tumescent Anesthesia for Dermatosurgical Procedures Other Than Liposuction , 2020, Journal of cutaneous and aesthetic surgery.

[5]  W. van der Stuijt,et al.  Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant? , 2020, Netherlands Heart Journal.

[6]  R. Weiss,et al.  Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement , 2020, The Journal of innovations in cardiac rhythm management.

[7]  Anthony Trela,et al.  Pectoral Nerve Blocks Decrease Postoperative Pain and Opioid Use After Pacemaker or Implantable Cardioverter-Defibrillator Placement in Children. , 2020, Heart rhythm.

[8]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.

[9]  C. Martignani,et al.  Serratus anterior plane block in subcutaneous implantable cardioverter defibrillator implantation: A case‐control analysis , 2019, Journal of cardiovascular electrophysiology.

[10]  E. Daoud,et al.  Implantation of subcutaneous defibrillator is feasible and safe with monitored anesthesia care , 2019, Pacing and clinical electrophysiology : PACE.

[11]  P. Lambiase,et al.  Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results. , 2019, Heart rhythm.

[12]  M. Irwin,et al.  Anaesthetic considerations in nonagenarians and centenarians. , 2019, Current opinion in anaesthesiology.

[13]  S. Al‐Khatib,et al.  The subcutaneous implantable cardioverter-defibrillator in review. , 2019, American heart journal.

[14]  Yohei Kawatani,et al.  Subpectoral pacemaker implantation under tumescent local analgesia , 2019, Journal of surgical case reports.

[15]  I. Chetter,et al.  A Randomised Clinical Trial of Buffered Tumescent Local Anaesthesia During Endothermal Ablation for Superficial Venous Incompetence. , 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[16]  William J. Bryant,et al.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2018, Circulation.

[17]  T. Rassaf,et al.  Conscious sedation during subcutaneous implantable cardioverter-defibrillator implantation using the intermuscular technique , 2018, Journal of Interventional Cardiac Electrophysiology.

[18]  Paari Dominic,et al.  Routine DFT testing in patients undergoing ICD implantation does not improve mortality: A systematic review and meta‐analysis , 2018, Journal of arrhythmia.

[19]  Timothy R. McClernon,et al.  Anesthesia for subcutaneous implantable cardioverter‐defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physicians , 2018, Pacing and clinical electrophysiology : PACE.

[20]  K. Ellenbogen,et al.  Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads , 2018, Journal of the American Heart Association.

[21]  J. DiNicolantonio,et al.  Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies. , 2017, JACC. Clinical electrophysiology.

[22]  M. Shoukri,et al.  Subcutaneous Implantable Cardioverter Defibrillators Implantation Without Defibrillation Threshold Testing: A Single Center Experience , 2017, Cardiology research.

[23]  Michael R Gold,et al.  Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results. , 2017, Heart rhythm.

[24]  Pier D Lambiase,et al.  Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study. , 2017, Journal of the American College of Cardiology.

[25]  V. Reddy,et al.  Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing. , 2017, Journal of the American College of Cardiology.

[26]  A. Wilde,et al.  Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy. , 2016, Journal of the American College of Cardiology.

[27]  A. Boonstra,et al.  Cut-Off Points for Mild, Moderate, and Severe Pain on the Numeric Rating Scale for Pain in Patients with Chronic Musculoskeletal Pain: Variability and Influence of Sex and Catastrophizing , 2016, Front. Psychol..

[28]  J. Blitz,et al.  Increasing body mass index and the incidence of intraoperative hypoxemia. , 2016, Journal of clinical anesthesia.

[29]  T. O. Prasetyono,et al.  The Onset and Duration of Action of 0.2% Lidocaine in a One-per-Mil Tumescent Solution for Hand Surgery , 2016, Archives of plastic surgery.

[30]  D. Jeske,et al.  Estimated Maximal Safe Dosages of Tumescent Lidocaine , 2016, Anesthesia and analgesia.

[31]  J. Prutkin,et al.  EARLY USE OF THE SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN THE UNITED STATES: A REPORT FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY , 2016 .

[32]  P. De Filippo,et al.  Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience , 2016, Journal of arrhythmia.

[33]  G. Hindricks,et al.  Patient discomfort following catheter ablation and rhythm device surgery. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[34]  J. Pogue,et al.  Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE) , 2015, The Lancet.

[35]  F. Chung,et al.  Complications of general anesthesia. , 2013, Clinics in plastic surgery.

[36]  F. Chung,et al.  Practice Guidelines for Postanesthetic Care: An Updated Report by the American Society of Anesthesiologists Task Force on Postanesthetic Care , 2013, Anesthesiology.

[37]  M Juhani Junttila,et al.  Sudden Cardiac Death Caused by Coronary Heart Disease , 2012, Circulation.

[38]  S. Viskin,et al.  The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. , 2008, Heart rhythm.

[39]  Robert C. Coghill,et al.  Attentional Modulation of Spatial Integration of Pain: Evidence for Dynamic Spatial Tuning , 2007, The Journal of Neuroscience.

[40]  O. K. Andersen,et al.  Mental stress inhibits pain perception and heart rate variability but not a nociceptive withdrawal reflex. , 2004, Acta physiologica Scandinavica.

[41]  Jimmy Thomas.  Adjunctive Tumescent Technique in Massive Resections , 2001, Aesthetic Plastic Surgery.

[42]  R. Moy,et al.  Tumescent Anesthesia with a Lidocaine Dose of 55 mg/kg Is Safe for Liposuction , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[43]  S. Salasche,et al.  Surgical pearl: hydroexpansion with local anesthesia. , 1995, Journal of the American Academy of Dermatology.

[44]  J. Klein.  The Tumescent Technique for Lipo-Suction Surgery , 1987 .

[45]  A. Wilde,et al.  Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation Techniques , 2017, Circulation. Arrhythmia and electrophysiology.

[46]  William J. Bryant,et al.  Practice Guideline: Executive Summary2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2017 .

[47]  J. O'Rourke,et al.  Tumescent anaesthesia. , 2013, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.